A new hepatitis C vaccination program launched in Israel in March 2016 was launched to address the shortage of hepatitis C vaccines.
The program, which covers 1.5 million people, is one of several initiatives that have emerged to address a severe shortage of vaccine doses, which has resulted in the country facing an epidemic of the virus.
The Israeli health ministry has been testing the effectiveness of the vaccine, and in a press release this week it stated that the results showed that the vaccine is safe and effective.
The vaccine is also designed to address concerns about the efficacy of other vaccines used in the region.
It is currently being tested in a study in the US, and if approved, it could become the first such vaccine to reach Israel.
The announcement came amid an escalation of the outbreak, with at least 11 people infected with the virus in Israel, with seven people dying from the disease.
The latest case was found in Tel Aviv on Thursday.HIV vaccine shortageA study published by the Israeli health authority on Monday revealed that the number of people infected by the virus is rising in Israel.
A total of 10.6 million people have been infected with HIV, with an additional 2.8 million infected by another virus.
As of June 2016, nearly 6 million people were living with the infection.
In a separate study published in the Journal of Infectious Diseases, researchers reported that in the first six months of the year, 665 people had been diagnosed with HIV.
The latest outbreak was a result of the introduction of new drug combinations and other strategies to reduce the amount of the drug used in treatments for HIV.
The introduction of an HIV vaccine is one such strategy.
Israel has been under intense pressure from the United Nations, which estimates that the virus has infected as many as 10 million people and that at least 8 million are living with it.
Last week, the country’s Minister of Health, David Herzog, urged citizens to vaccinate themselves and said that he would not allow them to get sick.
According to the report published by Haaretz, the first dose of the new vaccine will be distributed in September, and a second batch will be delivered in October.
The report added that, although it has not been approved by the government, the vaccine can be used by anyone, including the elderly.
According the report, there is no evidence to show that it is more effective than other vaccines.
“It is still very early days and there is still a lot to learn about the effectiveness and safety of the current vaccine,” said Dr. Shlomo Alshechib, the head of the study and head of immunization services at the National Institutes of Health.
The minister’s comments were met with criticism from the World Health Organization (WHO).
In a statement on Monday, the WHO said that the Israeli vaccine is “not as effective as expected, and that it cannot be used as a long-term vaccine for preventing HIV infection.”
The organization said that it would continue to monitor the health of the population and will recommend new vaccines for use in developing countries.
Israel is not the only country in the world facing a shortage of vaccines.
According, the International Agency for Research on Cancer has said that, between 2007 and 2015, the number the number in developed countries increased from 1.6 to 2.4 million.